IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
32 hedge funds and large institutions have $7.54M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
VKH
1
Virtu KCG Holdings
New York
|
$0 |
2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
3 |
CC
3
Callan Capital
La Jolla,
California
|
$157K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$1K |
5 |
5
Morgan Stanley
New York
|
$9K |